JP2003531122A - 治療方法 - Google Patents

治療方法

Info

Publication number
JP2003531122A
JP2003531122A JP2001576034A JP2001576034A JP2003531122A JP 2003531122 A JP2003531122 A JP 2003531122A JP 2001576034 A JP2001576034 A JP 2001576034A JP 2001576034 A JP2001576034 A JP 2001576034A JP 2003531122 A JP2003531122 A JP 2003531122A
Authority
JP
Japan
Prior art keywords
alkyl
group
het
azepan
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001576034A
Other languages
English (en)
Japanese (ja)
Inventor
マックスウェル・ディ・カミングズ
ロバート・ダブリュー・マーキス・ジュニア
ル・ユ
スコット・ケイ・トンプソン
ダニエル・エフ・ベーバー
デニス・エス・ヤマシタ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JP2003531122A publication Critical patent/JP2003531122A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2001576034A 2000-04-18 2001-04-17 治療方法 Withdrawn JP2003531122A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19771700P 2000-04-18 2000-04-18
US60/197,717 2000-04-18
PCT/US2001/012386 WO2001078734A1 (en) 2000-04-18 2001-04-17 Methods of treatment

Publications (1)

Publication Number Publication Date
JP2003531122A true JP2003531122A (ja) 2003-10-21

Family

ID=22730469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001576034A Withdrawn JP2003531122A (ja) 2000-04-18 2001-04-17 治療方法

Country Status (5)

Country Link
EP (1) EP1303281A4 (de)
JP (1) JP2003531122A (de)
AU (1) AU2001253560A1 (de)
CO (1) CO5280093A1 (de)
WO (1) WO2001078734A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157828A1 (en) * 2001-05-17 2004-08-12 Ren Xie Protease inhibitors
AU2003273697A1 (en) * 2002-10-08 2004-05-04 Merck Frosst Canada Ltd 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
EP2719700A1 (de) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivate als cysteine proteinase inhibitoren

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012277A3 (cs) * 1998-12-23 2001-11-14 Smithkline Beecham Corporation Inhibitory proteázy
WO2001034154A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
JP2003513926A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034156A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1351930A4 (de) * 1999-11-10 2004-09-15 Smithkline Beecham Corp Protease inhibitoren
JP2003513956A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034160A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034155A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
CA2404206A1 (en) * 2000-03-21 2001-09-27 Smithkline Beecham Corporation Protease inhibitors

Also Published As

Publication number Publication date
EP1303281A4 (de) 2006-02-15
EP1303281A1 (de) 2003-04-23
CO5280093A1 (es) 2003-05-30
WO2001078734A1 (en) 2001-10-25
AU2001253560A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
US7563784B2 (en) Protease inhibitors
KR100979577B1 (ko) 2형 진성 당뇨병의 치료를 위한11-베타-하이드록시스테로이드 탈수소효소의 억제제로서1-설폰일-피페리딘-3-카복실산 아마이드 유도체
RU2158731C2 (ru) Производные ароилпиперидина или их соли, фармацевтический препарат на их основе и способ их получения
AU2001243441A1 (en) Protease inhibitors
JP2001525809A (ja) プロテアーゼ阻害剤
JP2004509083A (ja) 治療方法
RU2156250C2 (ru) Производные хромона, способ их получения и фармацевтическая композиция
JP2003513956A (ja) プロテアーゼ阻害剤
JP2004526662A (ja) プロテアーゼ阻害剤
JP2003531122A (ja) 治療方法
JP2002533452A (ja) プロテアーゼ阻害剤
US20030114437A1 (en) Protease inhibitors
US20040157828A1 (en) Protease inhibitors
US20040034013A1 (en) Methods of treatment
US20040192674A1 (en) Cathepsin L inhibitors
JP2005513083A (ja) プロテアーゼ阻害剤
EP1384713B1 (de) 4-Amino-azepan-3-on-Derivate als Protease-Inhibitors
JP2003513972A (ja) プロテアーゼ阻害剤
US20030044399A1 (en) Method of treatment
US20040038965A1 (en) Protease inhibitors
CZ395399A3 (cs) Inhibitory proteasy

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20080701